Actinium Pharmaceuticals (ATNM) executive compensation, 2025 proxy

Sandesh Seth, Chairman and Chief Executive Officer, was paid $1.2M in 2024, down 75% from $4.7M the year before.

Filed
November 5, 2025
Annual meeting
November 26, 2025
Pay year
2024
Named executives
2
CEO total pay
$1.2M-75% vs prior year
CEO 2024 Salary
$733,200Base salary for fiscal 2024
CEO 2025 Salary
$762,320Base salary for fiscal 2025
CEO 2024 Bonus
$440,000Paid based on prior year performance
CFO 2024 Salary
$436,800Base salary for fiscal 2024
CFO 2024 Bonus
$145,000Paid based on prior year performance

How Seth was paid

$1.2M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary62%Bonus38%

Named executive officers

ExecutiveTotal
Sandesh SethChairman and Chief Executive Officer$1,173,200
Steve O’LoughlinChief Financial Officer$581,800

What changed and why

  • $1.2MCEO total compensation decreased to $1,173,200 in 2024 from $4,705,000 in 2023.
  • $0CEO option awards were $0 in 2024 compared to $3,500,000 in 2023.
  • $733KBase salary for CEO Sandesh Seth was set at $733,200 for 2024 and $762,320 for 2025.
  • 2.39MBoard approved cancellation of certain stock options totaling 2.39 million shares for CEO in 2025.
  • $582KCFO Steve O’Loughlin total compensation decreased to $581,800 in 2024 from $1,490,000 in 2023.

Other Actinium Pharmaceuticals proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.